Venous thromboembolism Clinical Trials
Recruiting venous thromboembolism studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat venous thromboembolism. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting venous thromboembolism studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting venous thromboembolism trials
Pulmonary Embolism in Patients With Acute Heart Failure (PEHF Study)
Statins to Prevent Cancer Associated Blood Clots
STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism
Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients: a Multicenter Double Blind Randomised Controlled Trial
Aspiration Thrombectomy Using the Symphony or Prodigy System
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism
Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study
Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.
Implementing VTE Prevention in Ambulatory Cancer Care
A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA
Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Variations in the Hemostatic System Induced by a Standardized Walking Test
Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)
Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial
CoMbination of Data From European Cohorts as Part of the European MORPHEUS Project [HORIZON-HLTH-2022-11-01] - "MC-MORPHEUS".
GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis
The Gynecological Cancer Associated Thrombosis (GynCAT) Study
THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
GEKO Venous Thromboembolism Prevention Study
Evaluation of the SCALED (SCaling AcceptabLE cDs)
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
Venous Thromboembolism Prevention in Outpatients With Glioma
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters
DOAC in Chinese Patients With Atrial Fibrillation
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
NOACs Use in AF or VTE (SUNSHINE Registry)
Impact of COVID-19 Vaccines on Cerebrovascular Health
Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
Caprini Score in Venous Surgery: a Prospective Cohort Study
Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT
Venous thromboembolism clinical trials — common questions
Are venous thromboembolism clinical trials free to join?
Yes. Participating in a venous thromboembolism clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a venous thromboembolism clinical trial?
Each venous thromboembolism study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a venous thromboembolism trial near me?
Use the location controls above. We'll show recruiting venous thromboembolism trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many venous thromboembolism trials are recruiting right now?
We're currently tracking roughly 20 recruiting venous thromboembolism trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.